Dr. Renato G. Martins on Nivolumab and its Role as a Second-Line Treatment in NSCLC
Published: | Updated:
​Renato G. Martins, MD, MPH, discusses why nivolumab is not ready to move up to being a firstline treatment in non
Renato G. Martins, MD, MPH
Articles by Renato G. Martins, MD, MPH
Latest Updated Articles
Dr. Renato G. Martins on Nivolumab and its Role as a Second-Line Treatment in NSCLCPublished: January 19th 2016 | Updated: April 18th 2020